We report a unique case of triple valve replacement with porcine bioprostheses in a young woman who remained asymptomatic 15 years later. Although in atrial fibrillation, she was taking only aspirin for anticoagulation until she delivered a normal child 2 years after surgery. Surprisingly, to date, her echocardiographic findings have remained the same as those after childbirth, and all the bioprostheses were functioning well, except for tricuspid annular calcification producing mild to moderate regurgitation.
Get full access to this article
View all access options for this article.
References
1.
BrownPSJrRobertsCSMcIntoshCLSwainJAClarkRE. Late results after triple-valve replacement with various substitute valves. Ann Thorac Surg1993;55:502–8.
2.
CarrierMHebertYPellerinMBouchardDPerraultLPCartierR. Tricuspid valve replacement: An analysis of 25 years of experience at a single center. Ann Thorac Surg2003;75:47–50.
3.
CohenSRSilverMAMcIntoshCLRobertsWC. Comparison of late (62 to 140 months) degenerative changes in simultaneously implanted and explanted porcine (Hancock) bioprostheses in the tricuspid and mitral valve positions in six patients. Am J Cardiol1984;53:1599–602.
4.
GuerraFBortolottiUThieneGMilanoAMazzuccoATalentiE. Long-term performance of the Hancock porcine bioprosthesis in the tricuspid position. A review of forty-five patients with fourteen-year follow-up. J Thorac Cardiovasc Surg1990;99:838–45.
5.
BjorkVOHenzeAPeterffyA. Can a mechanical heart valve be used in the tricuspid position? Experience with the Bjork-Shiley tilting disc valve in 70 patients. Eur Heart J1980;1:55–61.
6.
CobanogluAStarrA. Tricuspid valve surgery: Indications, methods, and results. Cardiovasc Clin1986;16:375–87.
7.
OhataTKigawaITohdaEWanibuchiY. Comparison of durability of bioprostheses in tricuspid and mitral positions. Ann Thorac Surg2001;71:S240–3.
8.
GlowerDDWhiteWDSmithLRYoungWGOldhamHNWolfeWG. In-hospital and long-term outcome after porcine tricuspid valve replacement. J Thorac Cardiovasc Surg1995;109:877–84.
